Searchable abstracts of presentations at key conferences in endocrinology

ea0050p262 | Neuroendocrinology and Pituitary | SFEBES2017

Establishing the prevalence of pituitary involvement in patients with IgG4-related disease.

Smith Christopher , Pusey Charles , Wernig Florian

Background: IgG4-related disease is a rare immune-mediated inflammatory condition associated with extensive multi-organ involvement. Little is known about the epidemiology of pituitary involvement as a part the IgG4-related disease spectrum.Objectives: We aimed to identify patients with pituitary involvement amongst those with systemic IgG4-related disease, and to compare these individuals to patients with isolated ...

ea0050p262 | Neuroendocrinology and Pituitary | SFEBES2017

Establishing the prevalence of pituitary involvement in patients with IgG4-related disease.

Smith Christopher , Pusey Charles , Wernig Florian

Background: IgG4-related disease is a rare immune-mediated inflammatory condition associated with extensive multi-organ involvement. Little is known about the epidemiology of pituitary involvement as a part the IgG4-related disease spectrum.Objectives: We aimed to identify patients with pituitary involvement amongst those with systemic IgG4-related disease, and to compare these individuals to patients with isolated ...

ea0062cb4 | Additional Cases | EU2019

Propylthiouracil-induced ANCA-associated vasculitis and agranulocytosis in a patient with Graves’ disease

Tomkins Maria , Smith Diarmuid , Agha Amar

42-year-old female with relapsing Graves’ disease treated with propylthiouracil (PTU) presented to the Emergency Department with a two-week history of fevers, night sweats, transient rash, arthralgia and fatigue. Five years previously she presented with Graves’ disease, TSH <0.02 mIU/l, FT4 of 39.8 pmol/l (9–16 pmol/l) and TSH receptor antibody positive with a titre of 11.3 IU/l. Initially treated with carbimazole therapy but developed an urticarial rash, lo...

ea0049gp159 | Neuroendocrinology &amp; Growth Hormones | ECE2017

Pituitary androgen receptor signalling is a novel negative regulator of prolactin production

O'Hara Laura , Tissier Paul Le , Smith Lee

The classical paradigm of lactotroph prolactin production and release is based around tonic inhibition by hypothalamic dopamine and stimulation by factors such as estrogen. We have recently shown that conditional ablation of pituitary androgen receptor (Foxg1-Cre ARKO) surprisingly does not change the concentration of circulating gonadotrophins but increases circulating prolactin in male mice; highlighting androgen signalling as a novel negative regulator of prolactin producti...

ea0059p022 | Adrenal and steroids | SFEBES2018

A review of short synacthen test results: what is the cut-off?

Frank Amy , Perry Colin , Smith Karen

Background/aims: The short synacthen test (SST) is a dynamic function test used to assess the hypothalamic pituitary adrenal axis. Interpretation requires consideration of sample timing and cortisol method. Currently the 30 minutes post-synacthen cortisol (CORT30) at NHS Greater Glasgow and Clyde (NHS GGC) is >450 nmol/l measured on the Abbott Architect. A large reference range study published a cut-off of >430 nmol/l for this method. This audit aims to document clinic...

ea0059ep80 | Neuroendocrinology and pituitary | SFEBES2018

A difficult case of Cushing’s disease with unexplained hypertension and rapid metabolic decompensation

Sutton Smith Mark , Cox Jeremy , Robinson Stephen

A 26 year old man of Angolan descent presented to the endocrine clinic with poorly controlled hypertension (systolic blood pressure >200 mmHg). He had been treated with Amlodipine for almost six years, and more recently the addition of Irbesatan and Indapamide had not led to adequate blood pressure control. His hypertension was diagnosed at age 19 and progressive features of Cushing’s disease had remained unnoticed, with truncal striae, easy bruising, myopathy, puffin...

ea0038p381 | Reproduction | SFEBES2015

A pragmatic review of patient satisfaction and testosterone replacement therapy

Smith Adam , Dickinson Sarah , Arber Michael

Introduction: In addition to safety and efficacy, patient satisfaction with treatment is potentially a key factor in maintaining therapy adherence. Testosterone replacement therapy (TRT) is provided using a variety of products with different features and routes of administration. These differing product characteristics may impact on patient satisfaction and adherence with a concomitant impact on well-being and health-related quality of life. The aim of this study was to explor...

ea0036P45 | (1) | BSPED2014

Using an electronic tablet to survey patient satisfaction in an adolescent transitional diabetes clinic at York, United Kingdom

Joy Reeba , Smith Dominic , Mannion Joanne

Objectives: To assess patient satisfaction with the transitional diabetes clinic service. Our transitional diabetes clinics (for 14–19 year olds) are run monthly by a multi disciplinary team comprising of a consultant, nurse and dietician each, from both adult and paediatric diabetes teams.Methods: An electronic tablet with the pre-programmed survey was handed out to 42 young people while they were waiting to be seen in clinic.<p class="abstext"...

ea0035p474 | Diabetes therapy | ECE2014

Is psychological support the missing ingredient in successful outcomes for pancreas transplantation: the importance of recognising and managing the ‘competitive patient'

Jackson Sue , Gleeson Kate , Smith Richard

Introduction: To date, psychological research on pancreatic transplantation has focused mainly on illness and quality of life. Research has been predominantly quantitative rendering it impossible to identify specific psychological issues faced by patients. Uniquely, this work considered post-transplant issues in the context of the pre-transplant psychological burden of patients with T1DM.Methods: 21 individuals with T1DM were interviewed (11 males; five ...

ea0034p224 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

DLK1/PREF1 prevents hepatosteatosis by elevating pituitary GH secretion

Charalambous Marika , daRocha Simao , Ferguson-Smith Anne

GH deficiency is clinically associated with non-alcoholic fatty liver disease. Here we describe a new in vivo model of pituitary GH modulation resulting in protection from hepatosteatosis, by over-expression of delta-like homologue 1 (Dlk1/Pref1) from endogenous control elements. This resulted in improved glucose tolerance with no primary defect in adipose tissue expansion, even under extreme metabolic stress. Rather, Dlk1 overexpression caused pitui...